论文部分内容阅读
目的:探讨肿瘤放疗患者医院感染的相关因素及控制管理措施。方法:医院在2013年1月~2015年1月收治的肿瘤放疗患者中,选择其中的200例作为研究对象,对其病历资料进行回顾性分析,分析肿瘤放疗患者的医院感染相关因素,并探讨针对性的控制管理措施。结果:200例肿瘤放疗患者中,发生医院感染患者49例,发生率为24.50%。发生医院感染的49例患者中,死亡12例,死亡率为24.50%;未发生医院感染的151例患者中,死亡15人,死亡率为9.90%。49例发生医院感染的肿瘤放疗患者中,呼吸系统感染25例、泌尿系统感染10例、消化系统感染5例、皮肤感染5例及其他感染4例,主要以呼吸系统感染与泌尿系统感染为主。结论:肿瘤放疗患者由于自身免疫系统遭到破坏,加上放射治疗后出现消化道功能障碍、骨髓功能抑制及其他副反应等,使患者成为医院感染的易感人群,患者的生命安全和治疗效果得不到保障,所以做好医院感染的控制措施相当重要。
Objective: To investigate the related factors and control measures of nosocomial infection in patients with tumor radiotherapy. Methods: From January 2013 to January 2015, the hospital selected 200 cases of tumor radiotherapy patients as the research object, the medical record data were retrospectively analyzed, and the related factors of nosocomial infection were analyzed and discussed Targeted control management measures. Results: Of 200 patients with tumor radiotherapy, 49 cases of nosocomial infection occurred, the incidence was 24.50%. Of 49 patients with nosocomial infections, 12 were fatal, with a mortality rate of 24.50%. Among 151 patients without nosocomial infection, 15 were fatal, with a mortality rate of 9.90%. Of the 49 patients with nosocomial infections, 25 were respiratory infections, 10 were urinary tract infections, 5 were digestive infections, 5 were skin infections and 4 were other infections, mainly respiratory and urinary tract infections . CONCLUSIONS: Patients with cancer radiotherapy have been compromised in the autoimmune system, combined with dysfunction of the digestive tract, suppression of bone marrow function and other side effects after radiotherapy, making the patients susceptible to nosocomial infections and their life safety and therapeutic efficacy No safeguards, so it is important to do a good job in the control of nosocomial infections.